Zenas BioPharma

(NASDAQ) ZBIO

Current Price$18.55

Market Cap$1.15B

Since IPO (2024)+0%

5 YearN/A

1 Year+92%

1 Month+10%

Zenas BioPharma Financials at a Glance

Market Cap

$1.15B

Revenue (TTM)

$0.00

Net Income (TTM)

-$425.15M

EPS (TTM)

-$9.10

P/E Ratio

-2.00

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$18.55

Volume

30,216

Open

$18.25

Price

$18.55

Volume

30,216

Open

$18.25

Previous Close

$18.55

Daily Range

$18.13 - $19.12

52-Week Range

$8.91 - $44.60

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$18.55

Volume

30,216

Open

$18.25

Previous Close

$18.55

Daily Range

$18.13 - $19.12

52-Week Range

$8.91 - $44.60

Estimated Earnings Date

Aug 12, 2026

ZBIO News

ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch

Seena HassounaMar 21, 2026

Chairman and CEO of Zenas BioPharma (ZBIO) Buys 36,928 Shares for $769,948

Cory RenauerOct 16, 2025

ZBIO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zenas BioPharma

Industry

Biotechnology

Sector

Health Care

Employees

167

Headquarters

Waltham, MA 02451, US

ZBIO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-137%

Return on Capital

-62%

Return on Assets

-57%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.15B

Shares Outstanding

63.13M

Volume

30.22K

Avg. Volume

700.35K

Financials (TTM)

Gross Profit

$10.00M

Operating Income

-$211.39M

EBITDA

-$370.43M

Operating Cash Flow

-$172.33M

Capital Expenditure

-$18.00K

Free Cash Flow

-$172.35M

Cash & ST Invst.

$343.19M

Total Debt

$79.96M

Zenas BioPharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$6.00K

-100.1%

Gross Margin

0.00%

N/A

Market Cap

$1.15B

N/A

Market Cap/Employee

$8.83M

N/A

Employees

130

N/A

Net Income

-$80.99M

-141.2%

EBITDA

-$74.35M

-120.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$717.21M

+129.6%

Total Debt

$351.73M

+28612.6%

Accounts Receivable

$1.10M

N/A

Inventory

$0.00

N/A

Long Term Debt

$350.69M

+110528.4%

Short Term Debt

$1.04M

+14.2%

Return on Assets

-56.86%

N/A

Return on Invested Capital

-61.63%

N/A

Free Cash Flow

-$75.20M

-102.9%

Operating Cash Flow

-$75.20M

-103.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

WVEWave Life Sciences Ltd.

WVEWave Life Sciences Ltd.$5.95+3.66%

AMLXAmylyx Pharmaceuticals, Inc.

AMLXAmylyx Pharmaceuticals, Inc.$15.25+1.33%

INBXInhibrx Biosciences, Inc.

INBXInhibrx Biosciences, Inc.$94.20+1.17%

ORICORIC Pharmaceuticals, Inc.

ORICORIC Pharmaceuticals, Inc.$8.63+3.85%

NVAXNovavax, Inc.

NVAXNovavax, Inc.$9.50+3.26%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$19.04+2.64%

NTLAIntellia Therapeutics, Inc.

NTLAIntellia Therapeutics, Inc.$15.20+4.47%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ICCMIceCure Medical

ICCMIceCure Medical$6.40+2.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.42-0.02%

NOKNokia

NOKNokia$13.83-0.01%

NUNu Holdings

NUNu Holdings$12.89+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.54-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.52+0.03%

HOODRobinhood Markets

HOODRobinhood Markets$105.20+0.09%

Questions About ZBIO

What is the current price of Zenas BioPharma?

Zenas BioPharma is trading at $18.55 per share.

What is the 52-week range for Zenas BioPharma?

Over the past 52 weeks, Zenas BioPharma has traded between $8.91 and $44.60.

How much debt does Zenas BioPharma have?

As of the most recent reporting period, Zenas BioPharma reported total debt of $351.73M.

How much cash does Zenas BioPharma have on hand?

Zenas BioPharma reported $500.22M in cash and cash equivalents in its most recent financial results.

What is Zenas BioPharma’s dividend yield?

Zenas BioPharma does not currently have a dividend yield.

Zenas BioPharma

Zenas BioPharma Financials at a Glance

ZBIO News

ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch

Chairman and CEO of Zenas BioPharma (ZBIO) Buys 36,928 Shares for $769,948

ZBIO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Zenas BioPharma

ZBIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Zenas BioPharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ZBIO

What is the current price of Zenas BioPharma?

What is the 52-week range for Zenas BioPharma?

How much debt does Zenas BioPharma have?

How much cash does Zenas BioPharma have on hand?

What is Zenas BioPharma’s dividend yield?

Premium Investing Services